Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSFER: Rebif New Formulation Transition in MS
NCT00619307Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Jul 2007
- Primary completion
- Apr 2008
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 3 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Merck KGaA. Started Jul 2007; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00619307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619307.